For confirmed deficiency or pernicious anaemia, NICE Clinical Knowledge Summaries recommend hydroxocobalamin 1mg intramuscularly, with frequency determined by the underlying cause and neurological involvement
July 2024: Roche reported early clinical data for CT-996, its once-daily oral GLP-1 receptor agonist, showing clinically meaningful weight loss after four weeks and supporting further development in obesity and type 2 diabetes
Related Blogs Related products
Finally, recent work explores the potential of BPC-157 in the treatment of psychiatric disorders
Vitamin D3, L-arginine, L-citrulline, and antioxidant supplementation enhances nitric oxide bioavailability and reduces oxidative stress in the vascular endothelium--clinical implications for cardiovascular system
When Your Provider May Recommend Both Medications Type 2 diabetes patients benefit most from combined metformin and GLP-1 therapy